Placeholder Banner

BIO Thanks Senators for Supporting Higher RFS Volumes

June 24, 2016

The Biotechnology Innovation Organization (BIO) today thanked a bipartisan group of 39 Senators for urging EPA to get the Renewable Fuel Standard (RFS) “back on track by setting blending targets where Congress intended and by removing the distribution waiver.” In particular, BIO thanked Sens. Charles Grassley (R-IA), Amy Klobuchar (D-MN), John Thune (R-SD), Dick Durbin (D-IL), Al Franken (D-MN), and Mark Kirk (R-IL).

Brent Erickson, Executive Vice President of BIO’s Industrial & Environmental Section, stated:

“BIO greatly appreciates the 39 Senators who have urged EPA to ensure that its final rule for 2017 promotes growth in the biofuel sector and captures economic opportunities here in the United States. The Senators understand that EPA’s waiver of RFS volumes in 2014, 2015 and 2016 continues to cause biofuel investment to fall.

“EPA acknowledges that its delays in rulemaking undercut investment in advanced biofuels. It fails to recognize, however, that its methodology continues to discourage investment in advanced biofuels. Investment patterns clearly demonstrate that EPA is sending a sustained market signal that disincentivizes advanced biofuels, causing a $22.4 billion shortfall in necessary investment.

“EPA must correct course in the final 2017 rule and ensure that the U.S. transportation fuel market is open to every gallon of renewable fuel that can be produced.”

The original letter can be found at: http://www.grassley.senate.gov/news/news-releases/epa-finalizes-rule-grassley-klobuchar-lead-bipartisan-group-39-senators-calling.

Discover More
BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…